SightfileU.S. market data from official filings

Companies › OKYO

OKYO PHARMA LTD (OKYO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001849296 · EDGAR filings · Updated 2026-07-28

OKYO PHARMA LTD (OKYO) has reported institutional ownership of 12.2%, with 12 institutional managers holding positions valued at $10.3M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
12.2%
Institutional managers
12
Reported 13F value
$10.3M
Data flags
1 active
from SEC filings

Filings this week (6)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, OKYO PHARMA LTD has 12 institutional holders and institutional ownership of 12.2%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2025-07-18 (recurring since 2022-08-15) — source filing. The authoritative details are those stated in the filing itself.

Related companies

ORGANIGRAM GLOBAL INC (OGI) · ANNOVIS BIO INC (ANVS) · SAFE PRO GROUP INC (SPAI) · SKYE BIOSCIENCE INC (SKYE) · BeyondSpring Inc (BYSI) · Pasithea Therapeutics Corp (KTTA)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.